Home › Glioma › North Carolina › Durham

Pag-aaral pangklinika para sa Glioma sa Durham, NC

Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nagre-recruitPhase 2

Duke University Medical Center, Durham

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Duke University Health System, Durham

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Duke University Health System, Durham

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Duke Cancer Institute, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Nagre-recruitPhase 1

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05609994

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2

Duke Cancer Center, Durham

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Lerapolturev (PVSRIPO) in GBM

Nagre-recruitPhase 2

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06177964

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Duke University Health System, Durham

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Nagre-recruitPhase 1

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04547777

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Duke University Health System, Durham

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

Nagre-recruitPhase 1

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06126744

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Nagre-recruitMaagang Phase 1

Duke University Health System, Durham

Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

Pag-aaral para sa Glioma sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.